Clinical trials
Enrolling by invitation Diabetes Mellitus trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 12 |
| 2025 | 8 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rutgers, The State University of New Jersey | 2 |
| Ataturk University | 1 |
| California Polytechnic State University-San Luis Obispo | 1 |
| Debre Berhan University | 1 |
| Dokuz Eylul University | 1 |
| Dow University of Health Sciences | 1 |
| Endogenex, Inc. | 1 |
| Gazi University | 1 |
| Jerry Dang | 1 |
| Mansoura University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 30 |
| Diabetes Mellitus, Type 2 | 4 |
| Hypertension | 4 |
| Chronic Disease | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Hyperlipidemias | 2 |
| Renal Insufficiency, Chronic | 2 |
| Adenocarcinoma | 1 |
| Diabetes, Gestational | 1 |
| Diabetic Foot | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.